("SeeMedX") today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its innovative, non-invasive cardiac monitoring device, designed ...

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients FDA ...

A new AI-enhanced ECG model, AIRE, accurately predicts mortality and heart disease risk, providing clinicians with actionable ...

("SeeMedX ") today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its innovative, non-invasive cardiac monitoring ...

Rollme has launched the X3 smartwatch, making a significant impact in the global market with its advanced health monitoring ...

Key Highlights of the SeeMedX Cardiac Monitoring Device: Real-time insights: Delivers actionable data on Zo (fluid status) and CO (cardiac output), enabling clinicians to make more timely decisions to ...

Why SeeMedX is Transformative for Heart Failure Treatment SeeMedX's non-invasive cardiac device provides precise hemodynamic measurements including ... Watch our impact video to see how SeeMedX's ...

Activity trackers, running watches, and fitness trackers come in many sizes, price ranges, and styles, so there are options ...

Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device, ...

Murata’s stretchable printed circuit offers both flexibility and the ability to stretch or deform without losing ...